Abstract
Due to an oversight, one of the author’s name was published wrong in the article entitled “A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation” in “Anti-Cancer Agents in Medicinal Chemistry, 2015, Vol. 15, No. 4, pp. 517.”
The correct names of all authors are given below: Samar Said Fatahala*, Emad Ahmed Shalaby, Shaymaa Emam Kassab and Mossad Said Mohamed to Mossad Sayed Mohamed
Anti-Cancer Agents in Medicinal Chemistry
Title:CORRIGENDUM A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation
Volume: 18 Issue: 10
Author(s):
Affiliation:
Abstract: Due to an oversight, one of the author’s name was published wrong in the article entitled “A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation” in “Anti-Cancer Agents in Medicinal Chemistry, 2015, Vol. 15, No. 4, pp. 517.”
The correct names of all authors are given below: Samar Said Fatahala*, Emad Ahmed Shalaby, Shaymaa Emam Kassab and Mossad Said Mohamed to Mossad Sayed Mohamed
Export Options
About this article
Cite this article as:
, CORRIGENDUM A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (10) . https://dx.doi.org/10.2174/187152061810181211124824
DOI https://dx.doi.org/10.2174/187152061810181211124824 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Positron Emission Tomography: Applications In Drug Discovery and Drug Development
Current Topics in Medicinal Chemistry Anti-Inflammatory and Anti-Oxidant Activity of a New Class of Phenyl- Pyrazolone Derivatives
Current Drug Discovery Technologies Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry Melatonin as Antioxidant Under Pathological Processes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Editorial [Hot Topic: Carbonic Anhydrases: Again, and Again, and Again (Executive Editor: Claudiu T. Supuran)]
Current Pharmaceutical Design Biocombinatorial Selection of Carbohydrate Binding Agents of Therapeutic Significance
Current Drug Discovery Technologies Targeting the EGF/HER Ligand-Receptor System in Cancer
Current Pharmaceutical Design Unveiling Cancer in IBD: Screening Colonoscopy or Chromoendoscopy
Current Drug Targets Editorial (Thematic Issue: Study and Prediction of Pharmacokinetic Drug-Drug Interactions)
Current Drug Metabolism Natural History of Ulcerative Colitis: Current Knowledge
Current Drug Targets Microarrays: Spotlight on Gene Function and Pharmacogenomics
Current Cancer Drug Targets Effects of Crosstalks Between Sumoylation and Phosphorylation in Normal Cellular Physiology and Human Diseases
Current Molecular Medicine A Fast and Efficient Chemiluminescence Method for Determination and Pharmacokinetic Study of Paclitaxel in Rat Plasma
Current Pharmaceutical Analysis Mass Spectrometric Imaging of the Nervous System
Current Pharmaceutical Design Contemporary Progress in the Synthesis and Reaction of 2-Arylbenzothiazole: A Review
Current Organic Chemistry Flavonoids with Therapeutic Potential in Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Anti Lung Cancer Activity of 3-Arylspiro[oxirane-2,3'- thiochroman]-4'-one Derivatives
Letters in Organic Chemistry Bioinformatics Study of RNA Interference on the Effect of HIF-1α on Apelin Expression in Nasopharyngeal Carcinoma Cells
Current Bioinformatics New Uracil Analogs with Exocyclic Methylidene Group as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery